Provided by Tiger Trade Technology Pte. Ltd.

Fidelity MSCI Health Care Index ETF

82.45
+1.311.61%
Post-market: 82.450.00000.00%19:30 EDT
Volume:159.48K
Turnover:13.12M
Market Cap:3.57B
PE:- -
High:82.56
Open:80.98
Low:80.93
Close:81.14
52wk High:85.46
52wk Low:67.77
Shares:43.35M
Float Shares:43.35M
Volume Ratio:0.63
T/O Rate:0.37%
Dividend:1.01
Dividend Rate:1.23%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Genmab Says Phase 3 Epcore DLBCL-2 Trial Shows Epcoritamab Plus R-CHOP Cuts Progression or Death Risk 51% in Newly Diagnosed DLBCL

Reuters
·
Oct 06

Genmab - Phase 3 Trial Shows 51% Reduction in Risk of Progression or Death in Dlbcl

THOMSON REUTERS
·
Oct 06

Genmab: Safety Profile of Epcoritamab When Administered in Combination with Standard of Care R-Chop was Generally Well Tolerated

THOMSON REUTERS
·
Oct 06

Genmab and Abbvie Announce Epcoritamab in Combination with R-Chop Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

THOMSON REUTERS
·
Oct 06

Eli Lilly Stock (LLY) Gains on Regulatory Win for Experimental Cancer Drug

TIPRANKS
·
Oct 06

Sector Update: Healthcare Stocks Rise Monday Afternoon

MT Newswires Live
·
Oct 06

Lilly Expands Oncology Footprint with FDA Win for Pancreatic Cancer Drug

Dow Jones
·
Oct 05

UnitedHealth Group Faces Texas AG Investigation Over Coverage Practices

MT Newswires Live
·
Oct 05

Eli Lilly treatment of pancreatic cancer granted orphan designation

TIPRANKS
·
Oct 05

UnitedHealth Group Faces AG Paxton Investigation Over Coverage Practices

MT Newswires Live
·
Oct 05

UnitedHealth under investigation by Texas AG amid alleged unlawful practices

TIPRANKS
·
Oct 05

Merck & Co Inc Stock (MRK) Moved Down by 3.04% on Oct 5: What Investors Need To Know

TradingKey
·
Oct 05

TRex Bio Files for Nasdaq IPO

MT Newswires Live
·
Oct 05

Merck, Caterpillar Share Losses Lead Dow's 269-Point Drop

Dow Jones
·
Oct 05

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Oct 05

Gate Bioscience Expands Collaboration and License Agreement with Lilly to Target Difficult-to-Drug Proteins

THOMSON REUTERS
·
Oct 05

Eli Lilly Presents New Ebglyss Data from Phase 3 ADorable-1 Pediatric Atopic Dermatitis Study at Fall Clinical 2026

Reuters
·
Oct 05

JPMorgan Adjusts Price Target on Merck & Co. to $165 From $150, Maintains Overweight Rating

MT Newswires Live
·
Oct 05

ReNerve shareholders back strategy as nerve repair portfolio gains momentum

TIPRANKS
·
Oct 05

Eli Lilly & Co (LLY) Gets a Buy from RBC Capital

TIPRANKS
·
Oct 03